Ikuro Maruyama

21.1k citations

412 papers · 15.9k indexed · 2 hit papers · h-index 65

Impact in

Clinical Biochemistry top 0.05%
- Advanced Glycation End Products research
Internal Medicine top 0.2%
- Venous Thromboembolism Diagnosis and Management

Papers in

Clinical Biochemistry 75
- Advanced Glycation End Products research 71
Internal Medicine 36
- Venous Thromboembolism Diagnosis and Management 36

Co-authors: Shingo Yamada Philip W. Majerus Isao Kitajima Teruto Hashiguchi Koichi Kawahara Takashi Ito Mitsuhiro Osame Akitoshi Ishizaka
Journals: Biochemical and Biophysical Research Communications (16 papers)Thrombosis Research (13 papers)Thrombosis and Haemostasis (10 papers)International Journal of Molecular Sciences (9 papers)Journal of Clinical Investigation (8 papers)
Partner nations: Japan United States Thailand

In The Last Decade

Ikuro Maruyama

401 papers receiving 15.5k citations

Hit Papers

align trajectories log scale

High mobility group box 1 protein interacts with multiple Toll-like receptors 2005 · 779 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2005 American Journal of Physiology-Cell Physiology
1991 International Immunology

Peers

Countries citing papers authored by Ikuro Maruyama

Since Specialization

Citations

This map shows the geographic impact of Ikuro Maruyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ikuro Maruyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ikuro Maruyama more than expected).

Fields of papers citing papers by Ikuro Maruyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ikuro Maruyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ikuro Maruyama. The network helps show where Ikuro Maruyama may publish in the future.

Co-authors

The 25 scholars most cited alongside Ikuro Maruyama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ikuro Maruyama Line = papers co-authored together Ikuro Maruyama links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Effects of different remote ischemia perconditioning methods on cerebral infarct volume and neurological impairment in rats Scientific Reports ·Shotaro Otsuka, Yuki Itashiki, Akira Tani, Teruki Matsuoka, Seiya Takada, Ryoma Matsuzaki, Kazuki Nakanishi, Kosuke Norimatsu, Yuta Tachibe, Riho Kitazato, Nao Nojima, Shogo Kakimoto, Kiyoshi Kikuchi, Ikuro Maruyama, Harutoshi Sakakima	2023	8
2	Stimulation of functional recovery via neurorepair mechanisms by the traditional Japanese Kampo medicine, Ninjin'yoeito, and physical exercise in a rat ischemic stroke model Journal of Ethnopharmacology ·Akira Tani, Harutoshi Sakakima, Shotaro Otsuka, Keita Mizuno, Kazuki Nakanishi, Kosuke Norimatsu, Seiya Takada, Teruki Matsuoka, Ryoma Matsuzaki, Tomomi Nakakogawa, Ikuro Maruyama	2022	7
3	Glycometabolic Regulation of the Biogenesis of Small Extracellular Vesicles Cell Reports ·Yoichiro Harada, Kazuki Nakajima, Takehiro Suzuki, Tomoko Fukushige, Kiyotaka Kondo, Junichi Seino, Yuki Ohkawa, Tadashi Suzuki, Hiromasa Inoue, Takuro Kanekura, Naoshi Dohmae, Naoyuki Taniguchi, Ikuro Maruyama	2020	26
4	HMGB proteins and arthritis Human Cell ·Noboru Taniguchi, Yasuhiko Kawakami, Ikuro Maruyama, Martin Lotz	2017	75
5	The use of hyaluronan in phacoemulsification protects human corneal endothelial cells from the noxious effect of extracellular histones. Investigative Ophthalmology & Visual Science ·Hiroki Kawano, Takashi Ito, Ikuro Maruyama, Teruto Hashiguchi, Kazunori Miyata, Taiji Sakamoto	2014	2
6	Paucity of CD34-positive cells and increased expression of high-mobility group box 1 in coronary thrombus with type 2 diabetes mellitus Atherosclerosis ·Atsushi Yamashita, Kensaku Nishihira, Yunosuke Matsuura, Takashi Ito, Kouichi Kawahara, Kinta Hatakeyama, Teruto Hashiguchi, Ikuro Maruyama, Hideo Yagi, Masanori Matsumoto, Yoshihiro Fujimura, Kazuo Kitamura, Yoshisato Shibata, Yujiro Asada	2012	24
7	Advanced malignant melanoma responds to Prunus mume Sieb. Et Zucc (Ume) extract: Case report and in vitro study Experimental and Therapeutic Medicine ·Shigeto Matsushita, Koichi Tada, Koichi Kawahara, Kazuhiro Kawai, Teruto Hashiguchi, Ikuro Maruyama, Takuro Kanekura	2010	19
8	Intraocular expression and release of high-mobility group box 1 protein in retinal detachment Laboratory Investigation ·Noboru Arimura, Yuya Kii, Teruto Hashiguchi, Koichi Kawahara, Kamal Krishna Biswas, Makoto Nakamura, Yasushi Sonoda, Keita Yamakiri, Akiko Okubo, Taiji Sakamoto, Ikuro Maruyama	2009	48
9	The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism Journal of Clinical Investigation ·Kazuhiro Abeyama, David M. Stern, Yuji Ito, Koichi Kawahara, Yasushi Yoshimoto, Motoyuki Tanaka, Tomonori Uchimura, Nobuo Ida, Yoshiaki Yamazaki, Shingo Yamada, Yasuhiko Yamamoto, Hiroshi Yamamoto, Satoshi Iino, Noboru Taniguchi, Ikuro Maruyama	2005	437
10	The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism Journal of Clinical Investigation ·Kazuhiro Abeyama, David M. Stern, Yuji Ito, Koichi Kawahara, Yasushi Yoshimoto, Motoyuki Tanaka, Tomonori Uchimura, Nobuo Ida, Yoshiaki Yamazaki, Shingo Yamada, Yasuhiko Yamamoto, Hiroshi Yamamoto, Satoshi Iino, Naoyuki Taniguchi, Ikuro Maruyama	2005	46
11	Orengedokuto inhibits neointimal formation, proliferation and migration of rat vascular smooth muscle cells in vivo and in vitro Hwa‐Jin Chung, Ying Liu, Ikuro Maruyama, 忠人谿	2005	0
12	Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation Thrombosis and Haemostasis ·Tsuyoshi Hatada, Tsutomu Nobori, Kazuhiro OKABAYASHI, Kazuo Maruyama, Yasunori Abe, Shinji Uemoto, Shingo Yamada, Ikuro Maruyama, Hideo Wada	2005	162
13	Importance of Tumor Necrosis Factor-α Cleavage Process in Post-Transplantation Lung Injury in Rats American Journal of Respiratory and Critical Care Medicine ·Taichiro Goto, Akitoshi Ishizaka, Fujio Kobayashi, Mitsutomo Kohno, Makoto Sawafuji, Sadatomo Tasaka, Eiji Ikeda, Yasunori Okada, Ikuro Maruyama, Koichi S. Kobayashi	2004	31
14	Contributions of High Mobility Group Box Protein in Experimental and Clinical Acute Lung Injury American Journal of Respiratory and Critical Care Medicine ·Hiroshi Ueno, Tomoyuki Matsuda, Satoru Hashimoto, Fumimasa Amaya, Yoshihiro Kitamura, Masaki Tanaka, Atsuko Kobayashi, Ikuro Maruyama, Shingo Yamada, Naoki Hasegawa, Junko Soejima, Hidefumi Koh, Akitoshi Ishizaka	2004	319
15	Synoviolin/Hrd1, an E3 ubiquitin ligase, as a novel pathogenic factor for arthropathy Genes & Development ·Tetsuya Amano, Satoshi Yamasaki, Naoko Yagishita, Kaneyuki Tsuchimochi, Hiroshi Shin, Koichi Kawahara, Satoko Aratani, Hidetoshi Fujita, Lei Zhang, Rie Ikeda, Ryoji Fujii, Naoki Miura, Setsuro Komiya, Kusuki Nishioka, Ikuro Maruyama, Akiyoshi Fukamizu, Toshihiro Nakajima	2003	204
16	HUMAN LACTIFEROUS MAMMARY GLAND CELLS PRODUCE VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND EXPRESS THE VEGF RECEPTORS, Flt-1 AND KDR/Flk-1 Cytokine ·Shoko Nishimura, Nobuaki Maeno, Katsuhiko Matsuo, Toshihiro Nakajima, Isao Kitajima, Hidehiko Saito, Ikuro Maruyama	2002	26
17	Blood coagulation equilibrium in rat liver microcirculation as evaluated by endothelial cell thrombomodulin and macrophage tissue factor Thrombosis Research ·Masahiro Arai, Satoshi Mochida, Akihiko Ohno, Itsuro Ogata, Hiroya Obama, Ikuro Maruyama, Kenji Fujiwara	1995	39
18	E5510 Antagonizes Thrombin Receptor Signals by Inhibiting NF-κB Activation Biochemical and Biophysical Research Communications ·Takeshi Nakajima, Isao Kitajima, Hiroshi Shin, Wataru Matsumoto, Yasuko Soejima, Ikuro Maruyama	1994	14
19	Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy Journal of Neuroimmunology ·Ryuji Kubota, Toshinobu Fujiyoshi, Shuji Izumo, Shinji Yashiki, Ikuro Maruyama, Mitsuhiro Osame, Shunro Sonoda	1993	79
20	Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. Journal of Clinical Investigation ·Isao Kitajima, Kazuhiko Yamamoto, Kanji Sato, Yuko Nakajima, Takeshi Nakajima, Ikuro Maruyama, Mitsuhiro Osame, K Nishioka	1991	95

About Ikuro Maruyama

Ikuro Maruyama is a scholar working on Clinical Biochemistry, Internal Medicine, Hematology, Immunology and Cardiology and Cardiovascular Medicine, having authored 412 papers that have together received 15.9k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (71 papers), Blood Coagulation and Thrombosis Mechanisms (71 papers), Venous Thromboembolism Diagnosis and Management (36 papers), Immune Response and Inflammation (27 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (20 papers), Sepsis Diagnosis and Treatment (20 papers), Antiplatelet Therapy and Cardiovascular Diseases (18 papers) and Protease and Inhibitor Mechanisms (18 papers). The work is most often cited by research in Clinical Biochemistry (2.6k citations), Internal Medicine (1.4k citations), Hematology (3.0k citations), Immunology (3.9k citations) and Critical Care and Intensive Care Medicine (602 citations). Ikuro Maruyama has collaborated with scholars based in Japan, United States and Thailand. Frequent co-authors include Shingo Yamada, Philip W. Majerus, Isao Kitajima, Teruto Hashiguchi, Koichi Kawahara, Takashi Ito, Mitsuhiro Osame, Akitoshi Ishizaka, Kazuhiro Abeyama and C. Elliott Bell. Their work appears in journals such as Biochemical and Biophysical Research Communications, Thrombosis Research, Thrombosis and Haemostasis, International Journal of Molecular Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact